SoftCo is pleased to announce that it is supporting an innovative new Lymphoma Tissue Bank at Guy’s and St. Thomas’ Hospital in London.

Lymphoma is cancer that develops in the lymph nodes and lymphatic system which makes up 3–4% of all cancers, making it the seventh most common form of cancer. Guy’s and St. Thomas’ Hospital are world-renowned for their expertise in the area and it was at Guy’s hospital in 1832 that the pathologist, Thomas Hodgkin, first recognized the disease.

The Lymphoma Tissue Bank will retain all prospective samples of patients diagnosed with lymphoma which will greatly aid further research directives particularly in the area of genomic and translational research. In particular, the Lymphoma Bank will assist in understanding the biological differences as to why some patients do not respond well to treatment. The samples will assist further analysis of the biological pathways relevant to these overall differential outcomes observed in patients with lymphoma.

“We would like to thank SoftCo for its very generous donation. The establishment of the new Lymphoma Tissue Bank is a great achievement for the future improvement in the treatment of these diseases.”

Paul Fields, Guy’s and St. Thomas’ Hospital

Guy’s and St Thomas hospital is in the top 3 NHS trusts for research in the UK. The trust has more than 2 million patient contacts per year, including 866,000 in community services. It employs approximately 13,500 staff with an annual turnover of £1.2 billion.  The hospital has an international reputation for undertaking pioneering clinical research and is part of King’s Health Partners, one of only six academic health science centres in England, and its National Institute for Health Research Biomedical Research Center leads the way in translational research and innovation.